Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.
| Image |  |
|---|---|
| Description | scientific article published on 26 April 2016 |
| Author/s |
author: David Moreno-Ramírez Nuria Ortega-Joaquín Aram Boada |
| Publication date | April 26, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |